Sensei Biotherapeutics (NASDAQ:SNSE) and Silverback Therapeutics (NASDAQ:SBTX) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, valuation, earnings, profitability and analyst recommendations.
Profitability
This table compares Sensei Biotherapeutics and Silverback Therapeutics' net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets |
---|
Sensei Biotherapeutics | N/A | N/A | N/A |
Silverback Therapeutics | N/A | N/A | N/A |
Analyst Recommendations
This is a summary of recent ratings and target prices for Sensei Biotherapeutics and Silverback Therapeutics, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score |
---|
Sensei Biotherapeutics | 0 | 0 | 4 | 0 | 3.00 |
Silverback Therapeutics | 0 | 0 | 4 | 0 | 3.00 |
Sensei Biotherapeutics presently has a consensus target price of $29.50, suggesting a potential upside of 108.78%. Silverback Therapeutics has a consensus target price of $50.25, suggesting a potential upside of 31.99%. Given Sensei Biotherapeutics' higher possible upside, analysts clearly believe Sensei Biotherapeutics is more favorable than Silverback Therapeutics.
Valuation & Earnings
This table compares Sensei Biotherapeutics and Silverback Therapeutics' revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio |
---|
Sensei Biotherapeutics | N/A | N/A | N/A | N/A | N/A |
Silverback Therapeutics | N/A | N/A | N/A | N/A | N/A |
Summary
Sensei Biotherapeutics beats Silverback Therapeutics on 1 of the 1 factors compared between the two stocks.